Medindia

X

Derma Sciences MEDIHONEY(TM) Featured in CBS National Broadcast

Tuesday, August 5, 2008 General News J E 4
Advertisement
PRINCETON, N.J., Aug. 4 Derma Sciences, Inc.(OTC Bulletin Board: DSCI), a provider of advanced wound care products,announced that on the CBS Evening News on Thursday, July 31, its key productMEDIHONEY was featured as part of a story about a specialty burn clinic inIraq run by US National Guard volunteers. The dressing is used as standardfirst-line therapy in place of the traditional silvadene antimicrobial creamat the Smith Gate Burn Clinic, the only service in Iraq offering burn care tochildren.

Derma Sciences CEO Ed Quilty stated, "It's wonderful to see the Smith GateBurn Clinic getting the national recognition it deserves. It's run byvolunteers, the supplies are all donated, and the compassionate care providedto these young children -- whose only other alternative within Iraq is a verypoor level of care -- is truly remarkable. They have been using MEDIHONEYdressings there now for the past two years, and it has proven to be aneffective first line of defense against infections, a common issue with burns.There are quite a few advantages of MEDIHONEY over the standard burnanti-infectives, and we are confident that global sales of the product to burncenters will be very strong."

The Smith Gate Burn Clinic (SGBC) is part of the military's civilianassistance program, and is located in a small shipping container locatedoutside the walls of the operation base. According to North Dakota NationalGuard soldier Col. Craig Lambrecht, M.D. -- the doctor who initially broughtMEDIHONEY to SGBC -- the clinic sees anywhere from 20 to 60 patients per day.Since electricity is not widely available in Iraq, the children there are athigh risk of burn injury due to their increased exposure to flammablesubstances and fire. They are also at risk of burns due to the consequence ofwar, such as from explosive devices. However, it is noted that the childrentreated at SGBC are not victims of Coalition fire or related action.

Dr. Lambrecht has stated that after he began using MEDIHONEY dressings,the patients healed more quickly and had fewer infections. Additionally, theIraqi families preferred MEDIHONEY over silvadene -- considered standard ofcare -- because it was natural and does not need to be changed as often.According to Dr. Lambrecht, "I would use the MEDIHONEY on burns on mychildren, as the first choice, without question," he said.

To find out more about Smith Gate Burn Clinic or to make a donation, clickhere: https://www.medcenterone.com/smithgate/index.htm

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advancedwound-care products. Its key product, MEDIHONEY, is sold throughout the worldby Derma Sciences and Comvita New Zealand -- the licensor of the patentedhoney-based technology -- and is the leading brand of honey-based dressingsfor the management of wounds and burns. The product has been shown to beeffective in a variety of wounds and burns, and was recently the focus of alarge-scale randomized controlled trial on leg ulcers. Derma has two productsin development: the BIOGUARD(TM) line of barrier gauze dressings, and DSC127,the company's novel angiotensin analog for accelerated wound healing and scarreduction. The barrier technology was licensed from Quick-Med in Q1 of 2007and is pending its initial FDA marketing clearance. DSC127 was licensed fromThe University of Southern California in Q4 of 2007 and is entering into aPhase II study, with anticipated initial patient enrollment to begin in Q3 of2008. For more information about Derma Sciences, Inc., visit its home page onthe Internet at http://www.dermasciences.com.To see the CBS broadcast, click here:http://www.cbsnews.com/sections/i_video/main500251.shtml?id=4312401n

SOURCE Derma Sciences, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Single-Pill Combinations Diovan HCT and Exforge Ap...
S
PDHI ConXus(R) Platform Allows Health Improvement ...